ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2011/10/26 | 1,204 | 1,204 | 1,185 | 1,197 | -3 | -0.3% | 8,000 |
2011/10/25 | 1,188 | 1,200 | 1,184 | 1,200 | +42 | +3.6% | 16,000 |
2011/10/24 | 1,174 | 1,174 | 1,157 | 1,158 | -15 | -1.3% | 11,000 |
2011/10/21 | 1,151 | 1,173 | 1,151 | 1,173 | -2 | -0.2% | 11,000 |
2011/10/20 | 1,199 | 1,199 | 1,175 | 1,175 | -32 | -2.7% | 3,000 |
2011/10/19 | 1,211 | 1,211 | 1,181 | 1,207 | -4 | -0.3% | 18,000 |
2011/10/18 | 1,228 | 1,228 | 1,211 | 1,211 | -7 | -0.6% | 11,000 |
2011/10/17 | 1,207 | 1,238 | 1,177 | 1,218 | +11 | +0.9% | 12,000 |
2011/10/14 | 1,206 | 1,208 | 1,201 | 1,207 | -11 | -0.9% | 22,000 |
2011/10/13 | 1,216 | 1,226 | 1,216 | 1,218 | -12 | -1% | 10,000 |
2011/10/12 | 1,210 | 1,239 | 1,206 | 1,230 | -2 | -0.2% | 22,000 |
2011/10/11 | 1,280 | 1,280 | 1,225 | 1,232 | -48 | -3.8% | 29,000 |
2011/10/07 | 1,291 | 1,291 | 1,271 | 1,280 | -24 | -1.8% | 22,000 |
2011/10/06 | 1,287 | 1,304 | 1,262 | 1,304 | +17 | +1.3% | 19,000 |
2011/10/05 | 1,319 | 1,319 | 1,280 | 1,287 | -32 | -2.4% | 10,000 |
2011/10/04 | 1,270 | 1,320 | 1,270 | 1,319 | +21 | +1.6% | 35,000 |
2011/10/03 | 1,310 | 1,310 | 1,287 | 1,298 | -22 | -1.7% | 20,000 |
2011/09/30 | 1,296 | 1,320 | 1,290 | 1,320 | +24 | +1.9% | 50,000 |
2011/09/29 | 1,296 | 1,304 | 1,279 | 1,296 | -2 | -0.2% | 44,000 |
2011/09/28 | 1,289 | 1,328 | 1,223 | 1,298 | +17 | +1.3% | 70,000 |
2011/09/27 | 1,234 | 1,281 | 1,209 | 1,281 | +77 | +6.4% | 101,000 |
2011/09/26 | 1,210 | 1,232 | 1,191 | 1,204 | -14 | -1.1% | 27,000 |
2011/09/22 | 1,240 | 1,240 | 1,213 | 1,218 | -24 | -1.9% | 17,000 |
2011/09/21 | 1,238 | 1,267 | 1,207 | 1,242 | -25 | -2% | 40,000 |
2011/09/20 | 1,270 | 1,279 | 1,266 | 1,267 | -25 | -1.9% | 21,000 |
2011/09/16 | 1,288 | 1,292 | 1,280 | 1,292 | +4 | +0.3% | 40,000 |
2011/09/15 | 1,281 | 1,288 | 1,260 | 1,288 | +8 | +0.6% | 47,000 |
2011/09/14 | 1,226 | 1,280 | 1,220 | 1,280 | +66 | +5.4% | 60,000 |
2011/09/13 | 1,189 | 1,221 | 1,188 | 1,214 | +31 | +2.6% | 30,000 |
2011/09/12 | 1,210 | 1,210 | 1,166 | 1,183 | -27 | -2.2% | 24,000 |
2011/09/09 | 1,200 | 1,210 | 1,195 | 1,210 | +11 | +0.9% | 62,000 |
2011/09/08 | 1,173 | 1,200 | 1,164 | 1,199 | +27 | +2.3% | 40,000 |
2011/09/07 | 1,146 | 1,172 | 1,130 | 1,172 | +39 | +3.4% | 21,000 |
2011/09/06 | 1,130 | 1,133 | 1,113 | 1,133 | +4 | +0.4% | 10,000 |
2011/09/05 | 1,126 | 1,133 | 1,125 | 1,129 | -8 | -0.7% | 20,000 |
2011/09/02 | 1,146 | 1,146 | 1,130 | 1,137 | -8 | -0.7% | 10,000 |
2011/09/01 | 1,174 | 1,174 | 1,142 | 1,145 | -9 | -0.8% | 28,000 |
2011/08/31 | 1,130 | 1,167 | 1,130 | 1,154 | +34 | +3% | 48,000 |
2011/08/30 | 1,110 | 1,127 | 1,110 | 1,120 | +20 | +1.8% | 22,000 |
2011/08/29 | 1,099 | 1,120 | 1,058 | 1,100 | +2 | +0.2% | 52,000 |
2011/08/26 | 1,092 | 1,098 | 1,090 | 1,098 | +10 | +0.9% | 30,000 |
2011/08/25 | 1,093 | 1,095 | 1,088 | 1,088 | -2 | -0.2% | 21,000 |
2011/08/24 | 1,087 | 1,092 | 1,087 | 1,090 | +17 | +1.6% | 11,000 |
2011/08/23 | 1,082 | 1,085 | 1,073 | 1,073 | -5 | -0.5% | 16,000 |
2011/08/22 | 1,091 | 1,091 | 1,075 | 1,078 | -6 | -0.6% | 7,000 |
2011/08/19 | 1,060 | 1,084 | 1,060 | 1,084 | +18 | +1.7% | 14,000 |
2011/08/18 | 1,072 | 1,072 | 1,066 | 1,066 | +2 | +0.2% | 4,000 |
2011/08/17 | 1,060 | 1,064 | 1,059 | 1,064 | +18 | +1.7% | 9,000 |
2011/08/16 | 1,069 | 1,072 | 1,039 | 1,046 | -24 | -2.2% | 19,000 |
2011/08/15 | 1,070 | 1,070 | 1,070 | 1,070 | +15 | +1.4% | 5,000 |
3201~
3250
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム